http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201492029-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
filingDate 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201492029-A1
titleOfInvention N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXYGEXYL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROCHINOLIN-3-CARBOXAMIDE
abstract The subject invention provides pharmaceutical compositions comprising laquinimod or a pharmaceutically acceptable salt thereof, an isolated N-ethyl-4-hydroxyl-1-methyl-5- (methyl (2,3,4,5,6-pentahydroxyhexyl) amino) -2- compound oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide or its salt, the compositions contain N-ethyl-4-hydroxyl-1-methyl-5- (methyl (2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide and methods for their preparation.
priorityDate 2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426202192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13163170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413344322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54677946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72194974

Total number of triples: 20.